Taisho Pharmaceutical's net sales FY 2012-2021
In the fiscal year 2021, the net sales of Taisho Pharmaceutical Holdings Co., Ltd. amounted to approximately 268.2 billion Japanese yen, the third lowest number of the past decade. Figures peaked in fiscal 2013 at almost 296 billion yen.
The main products of the Japanese pharmaceutical company include over-the-counter medicines and prescription pharmaceuticals.
The main products of the Japanese pharmaceutical company include over-the-counter medicines and prescription pharmaceuticals.
